Progression of Microstructural Damage in Spinocerebellar Ataxia Type 2: A Longitudinal DTI Study

References

1. 1.↵
   2. Auburger GW

   . Spinocerebellar ataxia type 2. Handb Clin Neurol 2012;103:423–36

   CrossRefPubMed
2. 2.↵
   2. Orr HT

   . Cell biology of spinocerebellar ataxia. J Cell Biol 2012;197:167–77

   Abstract/FREE Full Text
3. 3.↵
   2. Seidel K,
   3. Siswanto S,
   4. Brunt ER, et al

   . Brain pathology of spinocerebellar ataxias. Acta Neuropathol 2012;124:1–21

   CrossRefPubMedWeb of Science
4. 4.↵
   2. Jacobi H,
   3. Reetz K,
   4. du Montcel ST, et al

   . Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data. Lancet Neurol 2013;12:650–58

   CrossRefPubMed
5. 5.↵
   2. Mascalchi M,
   3. Vella A

   . Magnetic resonance and nuclear medicine imaging in ataxias. Handb Clin Neurol 2012;103:85–110

   PubMed
6. 6.↵
   2. Jacobi H,
   3. Hauser TK,
   4. Giunti P, et al

   . Spinocerebellar ataxia types 1, 2, 3 and 6: the clinical spectrum of ataxia and morphometric brainstem and cerebellar findings. Cerebellum 2012;11:155–66

   CrossRefPubMed
7. 7.↵
   2. Mascalchi M,
   3. Diciotti S,
   4. Giannelli M, et al

   . Progression of brain atrophy in spinocerebellar ataxia type 2: a longitudinal tensor-based morphometry study. PLoS One 2014;9:e89410

   CrossRefPubMed
8. 8.↵
   2. Agosta F,
   3. Pievani M,
   4. Sala S, et al

   . White matter damage in Alzheimer disease and its relationship to gray matter atrophy. Radiology 2011;258:853–63

   CrossRefPubMedWeb of Science
9. 9.↵
   2. Teipel SJ,
   3. Grothe M,
   4. Lista S, et al

   . Relevance of magnetic resonance imaging for early detection and diagnosis of Alzheimer disease. Med Clin North Am 2013;97:399–424

   CrossRefPubMed
10. 10.↵
    2. Zhang Y,
    3. Tartaglia MC,
    4. Schuff N, et al

    . MRI signatures of brain macrostructural atrophy and microstructural degradation in frontotemporal lobar degeneration subtypes. J Alzheimers Dis 2013;33:431–44

    PubMed
11. 11.↵
    2. Mascalchi M,
    3. Vella A,
    4. Ceravolo R

    . Movement disorders: role of imaging in diagnosis. J Magn Reson Imaging 2012;35:239–56

    CrossRefPubMed
12. 12.↵
    2. Tessa C,
    3. Giannelli M,
    4. Della Nave R, et al

    . A whole-brain analysis in de novo Parkinson disease. AJNR Am J Neuroradiol 2008;29:674–80

    Abstract/FREE Full Text
13. 13.↵
    2. Della Nave R,
    3. Ginestroni A,
    4. Tessa C, et al

    . Regional distribution and clinical correlates of white matter structural damage in Huntington disease: a tract-based spatial statistics study. AJNR Am J Neuroradiol 2010;31:1675–81

    Abstract/FREE Full Text
14. 14.↵
    2. Cosottini M,
    3. Giannelli M,
    4. Siciliano G, et al

    . Diffusion-tensor MR imaging of corticospinal tract in amyotrophic lateral sclerosis and progressive muscular atrophy. Radiology 2005;237:258–64

    CrossRefPubMedWeb of Science
15. 15.↵
    2. Guimaraes RP,
    3. D'Abreu A,
    4. Yasuda CL, et al

    . A multimodal evaluation of microstructural white matter damage in spinocerebellar ataxia type 3. Mov Disord 2013;28:1125–32

    CrossRefPubMed
16. 16.↵
    2. Mandelli ML,
    3. De Simone T,
    4. Minati L, et al

    . Diffusion tensor imaging of spinocerebellar ataxias types 1 and 2. AJNR Am J Neuroradiol 2007;28:1996–2000

    Abstract/FREE Full Text
17. 17.↵
    2. Salvatore E,
    3. Tedeschi E,
    4. Mollica C, et al

    . Supratentorial and infratentorial damage in spinocerebellar ataxia 2: a diffusion-weighted MRI study. Mov Disord 2014;29:780–86

    CrossRefPubMed
18. 18.↵
    2. Kang JS,
    3. Klein JC,
    4. Baudrexel S, et al

    . White matter damage is related to ataxia severity in SCA3. J Neurol 2014;261:291–99

    CrossRefPubMed
19. 19.↵
    2. Della Nave R,
    3. Ginestroni A,
    4. Tessa C, et al

    . Brain white matter damage in SCA1 and SCA2. An in vivo study using voxel-based morphometry, histogram analysis of mean diffusivity and tract-based spatial statistics. Neuroimage 2008;43:10–19

    CrossRefPubMedWeb of Science
20. 20.↵
    2. Della Nave R,
    3. Ginestroni A,
    4. Diciotti S, et al

    . Axial diffusivity is increased in the degenerating superior cerebellar peduncles of Friedreich's ataxia. Neuroradiology 2011;53:367–72

    CrossRefPubMedWeb of Science
21. 21.↵
    2. Della Nave R,
    3. Ginestroni A,
    4. Tessa C, et al

    . Brain white matter tracts degeneration in Friedreich ataxia. An in vivo MRI study using tract-based spatial statistics and voxel-based morphometry. Neuroimage 2008;40:19–25

    CrossRefPubMed
22. 22.↵
    2. Amlien IK,
    3. Fjell AM,
    4. Walhovd KB, et al

    . Mild cognitive impairment: cerebrospinal fluid tau biomarker pathologic levels and longitudinal changes in white matter integrity. Radiology 2013;266:295–303

    CrossRefPubMed
23. 23.↵
    2. Keil C,
    3. Prell T,
    4. Peschel T, et al

    . Longitudinal diffusion tensor imaging in amyotrophic lateral sclerosis. BMC Neurosci 2012;13:141

    CrossRefPubMed
24. 24.↵
    2. Pellecchia MT,
    3. Barone P,
    4. Vicidomini C, et al

    . Progression of striatal and extrastriatal degeneration in multiple system atrophy: a longitudinal diffusion-weighted MR study. Mov Disord 2011;26:1303–09

    CrossRefPubMed
25. 25.↵
    2. Reginold W,
    3. Lang AE,
    4. Marras C, et al

    . Longitudinal quantitative MRI in multiple system atrophy and progressive supranuclear palsy. Parkinsonism Relat Disord 2014;20:222–25

    CrossRefPubMed
26. 26.↵
    2. Teipel SJ,
    3. Meindl T,
    4. Wagner M, et al

    . Longitudinal changes in fiber tract integrity in healthy aging and mild cognitive impairment: a DTI follow-up study. J Alzheimers Dis 2010;22:507–22

    CrossRefPubMedWeb of Science
27. 27.↵
    2. Vandenberghe W,
    3. Demaerel P,
    4. Dom R, et al

    . Diffusion-weighted versus volumetric imaging of the striatum in early symptomatic Huntington disease. J Neurol 2009;256:109–14

    CrossRefPubMedWeb of Science
28. 28.↵
    2. Weaver KE,
    3. Richards TL,
    4. Liang O, et al

    . Longitudinal diffusion tensor imaging in Huntington's disease. Exp Neurol 2009;216:525–29

    CrossRefPubMedWeb of Science
29. 29.↵
    2. Sritharan A,
    3. Egan GF,
    4. Johnston L, et al

    . A longitudinal diffusion tensor imaging study in symptomatic Huntington's disease. J Neurol Neurosurg Psychiatry 2010;81:257–62

    Abstract/FREE Full Text
30. 30.↵
    2. Seppi K,
    3. Schocke MF,
    4. Mair KJ, et al

    . Progression of putaminal degeneration in multiple system atrophy: a serial diffusion MR study. Neuroimage 2006;31:240–45

    CrossRefPubMedWeb of Science
31. 31.↵
    2. Smith SM,
    3. Johansen-Berg H,
    4. Jenkinson M, et al

    . Acquisition and voxelwise analysis of multi-subject diffusion data with tract-based spatial statistics. Nat Protoc 2007;2:499–503

    CrossRefPubMedWeb of Science
32. 32.↵
    2. Smith SM,
    3. Jenkinson M,
    4. Johansen-Berg H, et al

    . Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 2006;31:1487–505

    CrossRefPubMedWeb of Science
33. 33.↵
    2. Pareyson D,
    3. Gellera C,
    4. Castellotti B, et al

    . Clinical and molecular studies of 73 Italian families with autosomal dominant cerebellar ataxia type I: SCA1 and SCA2 are the most common genotypes. J Neurol 1999;246:389–93

    CrossRefPubMedWeb of Science
34. 34.↵
    2. Filla A,
    3. DeMichele G,
    4. Caruso G, et al

    . Genetic data and natural history of Friedreich's disease: a study of 80 Italian patients. J Neurol 1990;237:345–51

    CrossRefPubMedWeb of Science
35. 35.↵
    2. Smith SM,
    3. Jenkinson M,
    4. Woolrich MW, et al

    . Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004;23(suppl 1):S208–19

    CrossRefPubMedWeb of Science
36. 36.↵
    2. Leemans A,
    3. Jones DK

    . The B-matrix must be rotated when correcting for subject motion in DTI data. Magn Reson Med 2009;61:1336–49

    CrossRefPubMedWeb of Science
37. 37.↵
    2. Cook PA,
    3. Bai Y,
    4. Nedjati-Gilani S, et al

    . Camino: open-source diffusion-MRI reconstruction and processing. In: Proceedings of the 14th Scientific Meeting of the International Society for Magnetic Resonance in Medicine, Seattle, Washington. May 6–12, 2006:2759
38. 38.↵
    2. Arsigny V,
    3. Fillard P,
    4. Pennec X, et al

    . Log-Euclidean metrics for fast and simple calculus on diffusion tensors. Magn Reson Med 2006;56:411–21

    CrossRefPubMed
39. 39.↵
    2. Zhang H,
    3. Avants BB,
    4. Yushkevich PA, et al

    . High-dimensional spatial normalization of diffusion tensor images improves the detection of white matter differences: an example study using amyotrophic lateral sclerosis. IEEE Trans Med Imaging 2007;26:1585–97

    CrossRefPubMedWeb of Science
40. 40.↵
    2. Ennis DB,
    3. Kindlmann G

    . Orthogonal tensor invariants and the analysis of diffusion tensor magnetic resonance images. Magn Reson Med 2006;55:136–46

    CrossRefPubMedWeb of Science
41. 41.↵
    2. Douaud G,
    3. Jbabdi S,
    4. Behrens TE, et al

    . DTI measures in crossing-fibre areas: increased diffusion anisotropy reveals early white matter alteration in MCI and mild Alzheimer's disease. Neuroimage 2011;55:880–90

    CrossRefPubMedWeb of Science
42. 42.↵
    2. Tessa C,
    3. Lucetti C,
    4. Giannelli M, et al

    . Progression of brain atrophy in the early stages of Parkinson's disease: a longitudinal tensor-based morphometry study in de novo patients without cognitive impairment. Hum Brain Mapp 2014;35:3932–44

    CrossRefPubMed
43. 43.↵
    2. Smith SM,
    3. Nichols TE

    . Threshold-free cluster enhancement: addressing problems of smoothing, threshold dependence and localisation in cluster inference. Neuroimage 2009;44:83–98

    CrossRefPubMedWeb of Science
44. 44.↵
    2. Rüb U,
    3. Seidel K,
    4. Ozerden I, et al

    . Consistent affection of the central somatosensory system in spinocerebellar ataxia type 2 and type 3 and its significance for clinical symptoms and rehabilitative therapy. Brain Res Rev 2007;53:235–49

    CrossRefPubMed
45. 45.↵
    2. Brenneis C,
    3. Bosch SM,
    4. Schocke M, et al

    . Atrophy pattern in SCA2 determined by voxel-based morphometry. Neuroreport 2003;14:1799–802

    CrossRefPubMedWeb of Science
46. 46.↵
    2. Goel G,
    3. Pal PK,
    4. Ravishankar S, et al

    . Gray matter volume deficits in spinocerebellar ataxia: an optimized voxel based morphometric study. Parkinsonism Relat Disord 2011;17:521–27

    CrossRefPubMedWeb of Science
47. 47.↵
    2. Lee YC,
    3. Liu CS,
    4. Wu HM, et al

    . The “hot cross bun” sign in the patients with spinocerebellar ataxia. Eur J Neurol 2009;16:513–16

    CrossRefPubMed
48. 48.↵
    2. Rosas HD,
    3. Liu AK,
    4. Hersch S, et al

    . Regional and progressive thinning of the cortical ribbon in Huntington's disease. Neurology 2002;58:695–701

    CrossRefPubMed
49. 49.↵
    2. Kipps CM,
    3. Duggins AJ,
    4. Mahant N, et al

    . Progression of structural neuropathology in preclinical Huntington's disease: a tensor based morphometry study. J Neurol Neurosurg Psychiatry 2005;76:650–55

    Abstract/FREE Full Text
50. 50.↵
    2. Thieben MJ,
    3. Duggins AJ,
    4. Good CD, et al

    . The distribution of structural neuropathology in pre-clinical Huntington's disease. Brain 2002;125:1815–28

    Abstract/FREE Full Text
51. 51.↵
    2. Ginestroni A,
    3. Battaglini M,
    4. Della Nave R, et al

    . Early structural changes in individuals at risk of familial Alzheimer's disease: a volumetry and magnetization transfer MR imaging study. J Neurol 2009;256:925–32

    CrossRefPubMedWeb of Science
52. 52.↵
    2. Stefanits H,
    3. Budka H,
    4. Kovacs GG

    . Asymmetry of neurodegenerative disease-related pathologies: a cautionary note. Acta Neuropathol 2012;123:449–52

    CrossRefPubMed
53. 53.↵
    2. Huang H,
    3. Fan X,
    4. Weiner M, et al

    . Distinctive disruption patterns of white matter tracts in Alzheimer's disease with full diffusion tensor characterization. Neurobiol Aging 2012;33:2029–45

    CrossRefPubMedWeb of Science
54. 54.↵
    2. Acosta-Cabronero J,
    3. Williams GB,
    4. Pengas G, et al

    . Absolute diffusivities define the landscape of white matter degeneration in Alzheimer's disease. Brain 2010;133:529–39

    Abstract/FREE Full Text
55. 55.↵
    2. Rosas HD,
    3. Lee SY,
    4. Bender AC, et al

    . Altered white matter microstructure in the corpus callosum in Huntington's disease: implications for cortical “disconnection.” Neuroimage 2010;49:2995–3004

    CrossRefPubMedWeb of Science
56. 56.↵
    2. Salat DH,
    3. Tuch DS,
    4. van der Kouwe AJ, et al

    . White matter pathology isolates the hippocampal formation in Alzheimer's disease. Neurobiol Aging 2010;31:244–56

    CrossRefPubMedWeb of Science
57. 57.↵
    2. Kelp A,
    3. Koeppen AH,
    4. Petrasch-Parwez E, et al

    . A novel transgenic rat model for spinocerebellar ataxia type 17 recapitulates neuropathological changes and supplies in vivo imaging biomarkers. J Neurosci 2013;33:9068–81

    Abstract/FREE Full Text
58. 58.↵
    2. Reetz K,
    3. Costa AS,
    4. Mirzazade S, et al

    . Genotype-specific patterns of atrophy progression are more sensitive than clinical decline in SCA1, SCA3 and SCA6. Brain 2013;136:905–17

    Abstract/FREE Full Text
59. 59.↵
    2. Velazquez-Perez L,
    3. Rodriguez-Labrada R,
    4. Canales-Ochoa N, et al

    . Progression of early features of spinocerebellar ataxia type 2 in individuals at risk: a longitudinal study. Lancet Neurol 2014;13:482–89

    CrossRefPubMed
60. 60.↵
    2. Klockgether T

    . Spinocerebellar ataxia type 2: progression before diagnosis. Lancet Neurol 2014;13:445–46

    CrossRefPubMed